TAILORED IMMUNOSUPPRESSION IN DE NOVO RENAL TRANSPLANTATION BASED ON IMMUNE FUNCTION MONITORING: A RANDOMISED CONTROLLED TRIAL

被引：0
|
作者：
Van Laecke, Steven [1 ]
Terryn, Wim [2 ]
Nagler, Evi [1 ]
Van Biesen, Wim [1 ]
Glorieux, Griet [1 ]
Schepers, Eva [1 ]
Vanholder, Raymond [1 ]
机构：
[1] Ghent Univ Hosp, Renal Div, Ghent, Belgium
[2] Jan Yperman, Renal Div, Ieper, Belgium
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP777
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [41] An open, prospective, randomised, controlled, multi-centre study comparing fixed dose vs. concentration controlled mycophenolate mofetil regimens for de novo patients following renal transplantation (the FDCC trial).
    Toenshoff, Burkhard
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 113 - 113
  • [42] Impact of de novo everolimus-based immunosuppression on wound healing and tissue regeneration in heart transplantation
    Zuckermann, A.
    Arizon, J.
    Wang, S. S.
    MacCherini, M.
    Vermes, E.
    Bara, C.
    Ross, H.
    Laufer, G.
    Lehmkuhl, H.
    Keogh, A. M.
    Sips, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S118 - S118
  • [43] A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation
    de Graav, Gretchen N.
    Baan, Carla C.
    Clahsen-van Groningen, Marian C.
    Kraaijeveld, Rens
    Dieterich, Marjolein
    Verschoor, Wenda
    von der Thusen, Jan H.
    Roelen, Dave L.
    Cadogan, Monique
    van de Wetering, Jacqueline
    van Rosmalen, Joost
    Weimar, Wilem
    Hesselink, Dennis A.
    TRANSPLANTATION, 2017, 101 (10) : 2571 - 2581
  • [44] Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial
    Stringer, Dominic
    Gardner, Leanne
    Shaw, Olivia
    Clarke, Brendan
    Briggs, David
    Worthington, Judith
    Buckland, Matthew
    Danzi, Guilherme
    Hilton, Rachel
    Picton, Michael
    Thuraisingham, Raj
    Borrows, Richard
    Baker, Richard
    McCullough, Keith
    Stoves, John
    Phanish, Mysore
    Shah, Sapna
    Shiu, Kin Yee
    Walsh, Stephen B.
    Ahmed, Aimun
    Ayub, Waqar
    Hegarty, Janet
    Tinch-Taylor, Rose
    Georgiou, Evangelos
    Bidad, Natalie
    Kilic, Aysenur
    Moon, Zoe
    Horne, Robert
    McCrone, Paul
    Kelly, Joanna
    Murphy, Caroline
    Peacock, Janet
    Dorling, Anthony
    ECLINICALMEDICINE, 2023, 56
  • [45] Everolimus versus mycophenolatemofetil in De Novo immunosuppression after lung transplantation - Interims analysis of a prospective, randomized, clinical trial
    Strueber, M.
    Stefan, F.
    Simon, A. R.
    Warnecke, G.
    Dierich, M.
    Haverich, A.
    Welte, T.
    Gottlieb, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S205 - S205
  • [46] Renal Function Outcomes With Tacrolimus QD After De Novo Liver Transplantation for Different Baseline eGFR: Ad Hoc Analysis From the DIAMOND Randomized Controlled Trial.
    Tisone, G.
    Klempnauer, J.
    Bechstein, W.
    Pirenne, J.
    Friman, S.
    Zhao, A.
    Isoniemi, H.
    Rostaing, L.
    Settmacher, U.
    Brown, M.
    Undre, N.
    Trunecka, P.
    TRANSPLANTATION, 2014, 98 : 710 - 711
  • [47] Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial
    Stringer, Dominic
    Gardner, Leanne
    Shaw, Olivia
    Clarke, Brendan
    Briggs, David
    Worthington, Judith
    Buckland, Matthew
    Danzi, Guilherme
    Hilton, Rachel
    Picton, Michael
    Thuraisingham, Raj
    Borrows, Richard
    Baker, Richard
    McCullough, Keith
    Stoves, John
    Phanish, Mysore
    Shah, Sapna
    Shiu, Kin Yee
    Walsh, Stephen B.
    Ahmed, Aimun
    Ayub, Waqar
    Hegarty, Janet
    Tinch-Taylor, Rose
    Georgiou, Evangelos
    Bidad, Natalie
    Kilic, Aysenur
    Moon, Zoe
    Horne, Robert
    McCrone, Paul
    Kelly, Joanna
    Murphy, Caroline
    Peacock, Janet
    Dorling, Anthony
    ECLINICALMEDICINE, 2023, 56
  • [48] Renal Function Outcomes With Tacrolimus QD After De Novo Liver Transplantation for Different Primary Diseases: Ad Hoc Analysis From The DIAMOND Randomized, Controlled Trial.
    Bechstein, W.
    Trunecka, P.
    Klempnauer, J.
    Pirenne, J.
    Bennet, W.
    Zhao, A.
    Isoniemi, H.
    Kamar, N.
    Settmacher, U.
    Brown, M.
    Undre, N.
    Tisone, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 160 - 161
  • [49] Renal Function Outcomes With Tacrolimus QD After De Novo Liver Transplantation for Different Baseline eGFR: Ad Hoc Analysis From the DIAMOND Randomized Controlled Trial.
    Tisone, G.
    Klempnauer, J.
    Bechstein, W.
    Pirenne, J.
    Friman, S.
    Zhao, A.
    Isoniemi, H.
    Rostaing, L.
    Settmacher, U.
    Brown, M.
    Undre, N.
    Trunecka, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 710 - 711
  • [50] EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    Saliba, F.
    Metselaar, H. J.
    Beckebaum, S.
    Duvoux, C.
    Navasa, M.
    Dong, G.
    Lopez, P.
    Nevens, F.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S79 - S80
12345